3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Pancreatic Neoplasms
16
Carcinoma, Non-Small-Cell Lung
16
Breast Neoplasms
14
Triple Negative Breast Neoplasms
12
Lung Neoplasms
12
Neoplasm Metastasis
11
Squamous Cell Carcinoma of Head and Neck
8
Ovarian Neoplasms
8
Endometrial Neoplasms
7
Fallopian Tube Neoplasms
6
Esophageal Neoplasms
5
Oropharyngeal Neoplasms
4
Neoplasms
4
Melanoma
4
Colorectal Neoplasms
4
Adenocarcinoma Of Esophagus
4
Mouth Neoplasms
3
Laryngeal Neoplasms
3
Cholangiocarcinoma
3
Carcinoma, Transitional Cell
3
Carcinoma
3
Inflammatory Breast Neoplasms
2
Hypopharyngeal Neoplasms
2
Head and Neck Neoplasms
2
Gallbladder Neoplasms
2
Esophageal Squamous Cell Carcinoma
2
Brenner Tumor
2
Anatomic Stage II Breast Cancer AJCC v8
2
Anatomic Stage I Breast Cancer AJCC v8
2
Adenocarcinoma
2
Interventions
ruxolitinib
13
Cyclophosphamide
5
Tacrolimus
4
fludarabine phosphate
3
Whole-Body Irradiation
3
Stem Cell Transplantation
3
Specimen Handling
3
Peripheral Blood Stem Cell Transplantation
3
Mycophenolic Acid
3
Cyclosporine
3
fludarabine
2
fedratinib
2
Sirolimus
2
Injections
2
Busulfan
2
Biopsy
2
11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene
2
veliparib
1
umbralisib
1
thymoglobulin
1
selinexor
1
reparixin
1
piperine
1
pegylated granulocyte colony-stimulating factor
1
navitoclax
1
luspatercept
1
letermovir
1
itacitinib
1
iadademstat
1
demethoxycurcumin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Primary Myelofibrosis
×
Taxes
×
90 days
×
Clear all
No trials found.